Four independent siRNA oligos, validated to deplete KIFC1 mRNA and/or protein (Supplementary Figure 6a, b), induced a substantial reduction of cell viability over a 6-day period only in the cell models with centrosome amplification, regardless of breast cancer subtype (Fig. 4c). The gene discussed is KIFC1; the disease is breast cancer.